Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02599324
Recruitment Status : Recruiting
First Posted : November 6, 2015
Last Update Posted : June 11, 2019
Sponsor:
Information provided by (Responsible Party):
Pharmacyclics LLC.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : May 2021
  Estimated Study Completion Date : May 2021